Back

Scraping up CHA2DS2-VASc - defining components of the acronym in a nationwide registry study

23 April 2021 (14:00 - 21:00)
Organised by:
Congress Presentation Part of: ePoster session Prevalence and Incidence of Atrial Fibrillation EHRA Premium Access EHRA 2021

About the speaker

Photo
Mr Elis Kouki

University of Helsinki, Helsinki (Finland)

286 More presentations in this session

Presentation thumbnail
Non-valvular atrial fibrillation recurrence after sinus rhythm restoring at different follow-up periods: phenotype-genotype high-risk groups, considering rs10465885 polymorphism in connexin-40 gene
Doctor T. Mikhalieva (Kyiv, UA)
Abstract Slides
Presentation thumbnail
Atrial fibrillation substrate mapping with decrement evoked potential mapping.
Doctor O. Salvador (Parla, ES)
Abstract Slides
Presentation thumbnail
Atrial tissue characterization by cardiac magnetic resonance and high-density mapping in patients with atrial fibrillation
Miss R. Adelino Recasens (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Proarrhythmic atrial structural and molecular remodeling with advancing age. Implications for post-coronary artery bypass grafting atrial fibrillation occurrence.
Doctor R. SERBAN (Targu Mures, RO)
Abstract Slides
Presentation thumbnail
Find me if you can: lessons learned using the novel cartofinder algorithm in a routine workflow for catheter ablation of atrial fibrillation
Doctor C. Sohns (Bad Oeynhausen, DE)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

EHRA 2021

23 April 2021 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Big data analytics to depict patient journey: demographics, calculation and the relative role of the CHA2DS2Vasc score components in patients diagnosed with atrial fibrillation in a tertiary hospital
29 August 2022
thumbnail
Congress Presentation
National cardiac registries: a systematic review
28 August 2020
thumbnail
Congress Presentation
Who missed out on anticoagulation? a nationwide temporal analysis of patients with new-onset atrial fibrillation and no anticoagulation
30 August 2025
thumbnail
Congress Presentation
Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources